Sung Ji Nam

Stock Analyst at Scotiabank

(2.09)
# 2,850
Out of 4,884 analysts
78
Total ratings
41.54%
Success rate
-5.79%
Average return

Stocks Rated by Sung Ji Nam

Castle Biosciences
May 21, 2025
Maintains: Sector Outperform
Price Target: $44$40
Current: $20.30
Upside: +97.04%
Biodesix
May 21, 2025
Maintains: Sector Outperform
Price Target: $3$2
Current: $0.27
Upside: +636.38%
Myriad Genetics
May 21, 2025
Downgrades: Sector Perform
Price Target: $20$6
Current: $5.60
Upside: +7.14%
Guardant Health
May 5, 2025
Maintains: Sector Outperform
Price Target: $52$57
Current: $50.50
Upside: +12.87%
Thermo Fisher Scientific
Apr 25, 2025
Maintains: Sector Perform
Price Target: $650$605
Current: $429.33
Upside: +40.92%
Bionano Genomics
Apr 2, 2025
Maintains: Sector Perform
Price Target: $1$4
Current: $3.37
Upside: +18.69%
Pacific Biosciences of California
Mar 25, 2025
Maintains: Sector Outperform
Price Target: $6$2
Current: $1.60
Upside: +25.00%
Exact Sciences
Feb 24, 2025
Maintains: Sector Outperform
Price Target: $70$73
Current: $53.36
Upside: +36.81%
Adaptive Biotechnologies
Feb 13, 2025
Maintains: Sector Outperform
Price Target: $10$12
Current: $11.80
Upside: +1.69%
Waters
Feb 13, 2025
Upgrades: Sector Outperform
Price Target: $430$450
Current: $350.22
Upside: +28.49%
Maintains: Sector Outperform
Price Target: $88$90
Current: $53.14
Upside: +69.36%
Maintains: Sector Outperform
Price Target: $54$62
Current: $38.17
Upside: +62.43%
Initiates: Sector Perform
Price Target: $265
Current: $203.20
Upside: +30.41%
Maintains: Sector Outperform
Price Target: $40$44
Current: $27.51
Upside: +59.94%
Maintains: Buy
Price Target: $40$35
Current: $19.24
Upside: +81.91%
Maintains: Sector Outperform
Price Target: $176$164
Current: $100.80
Upside: +62.70%
Assumes: Buy
Price Target: $6
Current: $5.21
Upside: +15.16%
Downgrades: Neutral
Price Target: n/a
Current: $20.06
Upside: -